BlackRock Advisors’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $719K | Buy |
69,847
+189
| +0.3% | +$1.95K | ﹤0.01% | 1962 |
|
|
2016
Q3 | $704K | Sell |
69,658
-1,674
| -2% | -$16.9K | ﹤0.01% | 1944 |
|
|
2016
Q2 | $801K | Buy |
71,332
+1,509
| +2% | +$16.9K | ﹤0.01% | 1833 |
|
|
2016
Q1 | $954K | Sell |
69,823
-374
| -0.5% | -$5.11K | ﹤0.01% | 1723 |
|
|
2015
Q4 | $1.33M | Sell |
70,197
-12,811
| -15% | -$243K | ﹤0.01% | 1564 |
|
|
2015
Q3 | $1.56M | Buy |
83,008
+28,181
| +51% | +$529K | ﹤0.01% | 1425 |
|
|
2015
Q2 | $816K | Sell |
54,827
-77,216
| -58% | -$1.15M | ﹤0.01% | 1781 |
|
|
2015
Q1 | $2M | Sell |
132,043
-108,606
| -45% | -$1.65M | ﹤0.01% | 1199 |
|
|
2014
Q4 | $3.21M | Buy |
240,649
+34,385
| +17% | +$458K | ﹤0.01% | 1052 |
|
|
2014
Q3 | $2.6M | Sell |
206,264
-72,653
| -26% | -$916K | ﹤0.01% | 1084 |
|
|
2014
Q2 | $2.82M | Buy |
278,917
+45,815
| +20% | +$463K | ﹤0.01% | 1062 |
|
|
2014
Q1 | $3.14M | Buy |
+233,102
| New | +$3.14M | ﹤0.01% | 1054 |
|